Zhongchao Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZCMD research report →
Price Chart
About the company
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs.
- CEO
- Weiguang Yang
- IPO
- 2020
- Employees
- 33
- HQ
- Shanghai, SH, CN
Get TickerSpark's AI analysis on ZCMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $33.35K
- P/E
- -0.01
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 1.48
- Div Yield
- 0.00%
- Gross Margin
- 43.84%
- Op Margin
- -54.43%
- Net Margin
- -55.47%
- ROE
- -32.44%
- ROIC
- -27.14%
Latest fiscal year · YoY change
- Revenue
- $11.37M-28.3%
- Gross Profit
- $4.83M-45.8%
- Op Income
- $-6,191,225
- Net Income
- $-6,310,153-881.0%
- EPS
- $-172.05-92.7%
- OCF Growth
- +157.4%
- FCF Growth
- +115.3%
- 52W High
- $967.20
- 52W Low
- $0.80
- 50D MA
- $1.54
- 200D MA
- $203.47
- Beta
- -0.01
- RSI (14)
- 27
- Avg Volume
- 5.84M
No earnings-call transcripts are available for ZCMD yet.
- Free Float
- 96.6%
- Shares Outstanding
- 104.19K
- Float Shares
- 100.63K
of shares held by institutions
4 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 21, 26 | Yang Weiguang | other | 2,500,000 |
| Jul 21, 26 | Yang Weiguang | other | 200,000 |
| Mar 18, 26 | Vassily Kevin | other | 0 |
| Mar 18, 26 | General John Conrad | other | 0 |
| Mar 18, 26 | Xu Pei | other | 0 |
| Mar 18, 26 | LI DAN | other | 0 |
| Mar 18, 26 | Yang Weiguang | other | 0 |
| Mar 18, 26 | Yang Weiguang | other | 0 |
| Mar 18, 26 | Yang Weiguang | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ZCMD coverage
Recent articles, reports, and earnings notes.
No research on ZCMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ZCMD report →Zhongchao Inc. Announces $5.0 Million Registered Direct Offering
prnewswire.com · Jul 23
Zhongchao Inc. Announces 1-for-3 Share Consolidation
prnewswire.com · Jun 25
Zhongchao Inc. Announces 1-for-31 Share Consolidation
prnewswire.com · Jun 4
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
gurufocus.com · May 29
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
prnewswire.com · May 29
Reviewing Standard BioTools (NASDAQ:LAB) & Zhongchao (NASDAQ:ZCMD)
defenseworld.net · Apr 27
Zhongchao Inc. (NASDAQ:ZCMD) Sees Large Decline in Short Interest
defenseworld.net · Mar 27
Zhongchao (NASDAQ:ZCMD) & Precipio (NASDAQ:PRPO) Financial Review
defenseworld.net · Mar 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.